Clinical Trial Update: A Twelve-month, Multicenter, Open-label, Randomized Study of the Safety, Tolerability and Efficacy of Everolimus With Basiliximab, Corticosteroids and Two Different Exposure Levels of Tacrolimus in de Novo Renal Transplant Recipients [Phase 4]

View source ↗

Summary

This Phase 4, multicenter, open-label, randomized study assessed safety, tolerability, and efficacy of everolimus with basiliximab, corticosteroids, and two exp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplantation

Drugs mentioned

• Basiliximab (basiliximab)
• Corticosteroids (corticosteroids)
• Everolimus (everolimus)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Novartis | Conditions: Renal Transplantation | Phase 4 | Status: COMPLETED | Results posted: 2011-01-19